GFACX
Price
$66.58
Change
-$0.13 (-0.19%)
Updated
Sep 20 closing price
TWCCX
Price
$61.54
Change
-$0.30 (-0.49%)
Updated
Sep 20 closing price
Ad is loading...

GFACX vs TWCCX

Header iconGFACX vs TWCCX Comparison
Open Charts GFACX vs TWCCXBanner chart's image
American Funds Growth Fund of Amer C
Price$66.58
Change-$0.13 (-0.19%)
VolumeN/A
CapitalizationN/A
American Century Ultra® C
Price$61.54
Change-$0.30 (-0.49%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GFACX vs TWCCX Comparison Chart
Loading...
VS
GFACX vs. TWCCX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and TWCCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 290B vs. TWCCX (25.2B). GFACX (0.00) and TWCCX (0.00) have matching dividends . GFACX was incepted earlier than TWCCX: GFACX (24 years) vs TWCCX (23 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. TWCCX (20.00). GFACX has a lower initial minimum investment than TWCCX: GFACX (250) vs TWCCX (2500). GFACX annual gain was more profitable for investors over the last year : 28.04 vs. TWCCX (25.36). TWCCX return over 5 years is better than : 58.73 vs. GFACX (45.21).
GFACXTWCCXGFACX / TWCCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years23 years-
Gain YTD21.05520.008105%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets290B25.2B1,151%
Annual Yield % from dividends0.000.00-
Returns for 1 year28.0425.36111%
Returns for 3 years-3.58-8.6341%
Returns for 5 years45.2158.7377%
Returns for 10 years52.5796.0555%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MYO3.890.06
+1.57%
Myomo
PVH97.13-0.42
-0.43%
PVH Corp
BKE43.85-0.77
-1.73%
Buckle (The)
BYON10.35-0.61
-5.57%
Beyond
QNRX0.54-0.03
-5.93%
Quoin Pharmaceuticals Ltd